The Hedgeweek Interview: Sandra Manzke, Manager, Matrix MAX Fund: Taking a longer-term view on the investment portfolio

Sandra Manzke, Chairman & CEO of MAXAM Capital Management, outlines the thinking behind the Matrix MAX Fund, aimed at the UK market. »


Harwood Committee proposes liberalised fund regime for Guernsey

A Committee tasked with ensuring the continuing health of Guernsey's investment sector has recommended fundamental changes to regulatory laws. »


Comment: "Guernsey's new approach will allay current criticisms"

Guernsey funds lawyer Advocate William Simpson believes regulatory developments will provide a strong competitive base for Guernsey's financial services industry. »


Reuters and Paladyne form strategic alliance

Reuters is combining its DataScope market data solution with Paladyne's front- to- back office hedge fund product suite. »


EDHEC disagrees with the ECB on the systemic risks of hedge funds

According to a recent article in the European Central Bank's Financial Services Review, hedge fund activities pose considerable risk to the financial system. »


CFTC clears BSE's Sensex futures contract for US offer and sale

The Bombay Stock Exchange (BSE) has been given the green light for the US launch of a futures contract based on the BSE's Sensitive Index (Sensex). »


Eze Castle Integration launches Eze Business Continuity Portfolio, expands Disaster Recovery Services

Eze Castle Integration has launched the Eze Business Continuity Portfolio, a range of managed IT and consulting services for hedge funds and investment firms. »


HSBC enters into global software license agreement with Trading Technologies

HSBC is to make Trading Technologies' (TT) high-speed XTRADER order-entry software available to its internal trading desks and customers. »


Risk Control addresses need for precise risk management techniques in structured products

Risk Control Limited, provider of advanced risk measurement software to financial institutions, has launched its new Risk Controller solution. »


Mellon HBV says Latium offer undervalues Ultraframe

Mellon HBV Alternative Strategies has challenged the offer made by Latium Holdings for Ultraframe, saying it prefers a recapitalization of the company. »


Upcoming events

3 days 17 hours from now - London
3 days 17 hours from now - Cartegena
3 days 17 hours from now - London
4 days 17 hours from now - Arizona
4 days 17 hours from now - Shanghai

Upcoming training